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Background: Peripheral arterial disease (PAD) can be diagnosed noninvasively by segmental blood pressuremeasurement and
calculating an ankle-brachial index (ABI) or toe-brachial index (TBI). The ABI is known to be unreliable in patients with
vascular stiffness and fails to detect the early phase of arteriosclerotic development. The toe vessels are less susceptible to vessel
stiffness, which makes the TBI useful. However, the diagnostic limits used in guidelines, clinical settings, and experimental
studies vary substantially. This review provides an overview of the evidence supporting the clinical use of the TBI.
Methods: A review of the literature identiﬁed studies reporting the use of the TBI regarding guideline recommendations,
normal populations, correlations to angiographic ﬁndings, and prognostic implications.
Results: Eight studies conducted in a normal population were identiﬁed, of which only one study used imaging techniques
to rule out arterial stenosis. A reference value of 0.71 was estimated as the lowest limit of normal based on the weighted
average in studies with preheating of the limbs. A further seven studies showed correlations of the TBI with angiographic
ﬁndings. The TBI had a sensitivity of 90% to 100% and a speciﬁcity of 65% to 100% for the detection of vessel stenosis.
Few studies investigated the value of the TBI as a prognostic marker for cardiovascular mortality and morbidity, and no
ﬁrm conclusions could be made. Studies have, however, shown correlation between the TBI and comorbidities such as
kidney disease, diabetes, and microvasculature disease.
Conclusions: In contrast to the well-deﬁned and evidence-based limits of the ABI, the diagnostic criteria for a pathologic
TBI remain ambiguous. Although several guidelines and reviews of PAD diagnostics recommend a TBI <0.70 as cutoff, it
is not strictly evidence-based. The current literature is not sufﬁcient to conclude a speciﬁc cutoff as diagnostic for PAD.
The current studies in normal populations and the correlation with angiography are sparse, and additional trials are
needed to further validate the limits. Large-scale trials are needed to establish the risk of morbidity and mortality for the
various diagnostic limits of the TBI. (J Vasc Surg 2013;58:231-8.)Peripheral arterial disease (PAD) is a manifestation of
generalized arteriosclerotic disease and leads to a range of
clinical conditions from asymptomatic disease to critical
ischemia.1 According to intersociety consensus guidelines,
PAD can be diagnosed noninvasively using segmental blood
pressure measurements by obtaining an ankle-brachial index
(ABI) or a toe-brachial index (TBI).1,2 The diagnostic limits
of the ABI have been validated in several large-scale studies,
and an ABI cutoff of #0.90 has been shown to be a strong
predictor of cardiovascular morbidity and mortality,3,4
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://dx.doi.org/10.1016/j.jvs.2013.03.044the diagnostic limits of the ABI have been shown to corre-
spond to angiographic ﬁndings, although studies have re-
ported diverging diagnostic accuracy for detecting vessel
stenosis in the lower limb.6
Conditions associated with media calciﬁcation, such as
diabetes, chronic kidney disease, or advanced age, can lead
to falsely elevated or falsely normal ankle pressures due to
vessel stiffness.7-9 The toe vessels, however, are less suscep-
tible to vessel stiffness, which makes the TBI useful.10,11 In
addition, the ABI has been shown to underestimate the
presence of media calciﬁcation compared with ﬁndings
from imaging techniques.12
Screening is the key to detecting early-stage disease and
allows the initiation of optimal preventive medical treat-
ment, which may reduce modiﬁable risk factors for patients
at risk for arteriosclerotic disease.13 In the current screening
algorithms, the most frequently used primary testing pro-
cedures include the Doppler-derived ABI, patient history,
and clinical examination. The TBI is usually limited to
patients who are expected to have vessel stiffness because
of relevant comorbidities or who have an elevated ABI.1
This approach is well known to underestimate the true
prevalence of PAD in the population, and in particular, fails
to detect the early phase of arteriosclerotic development.13
In addition, studies have shown that 14% to 27% of patients
referred for distal pressuremeasurements have a lowTBI but
a normal ABI.7,14,15 Approximately 60% of these patients
were not diagnosed with a disease associated with vessel231
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PAD according to the current screening algoritms.7,16
Implementation of the TBI as the standard test for PAD
could potentially allow detection of PAD patients who
remain undiagnosed by current standards.
Reliable measurement of the TBI has historically been
limited to vascular laboratories due to the expensive and
cumbersome techniques. Hand-held Doppler-based
methods are the primary tools for PAD diagnostics but
are less useful for the measurement of toe pressures.17
However, recently developed methods have been intro-
duced that allow access to bedside assessment of the TBI.
Early results are promising.16,18-22
In contrast to thewell-deﬁned and evidence-based limits
of the ABI, the diagnostic criteria for having a pathologic vs
a normal TBI remain ambiguous. Several guidelines1,23 and
reviews of PAD diagnostics24-27 recommend a TBI <0.70
as a cutoff, but other different limits are widely used in
observational studies and clinical settings.28-30 This may
reﬂect the lack of evidence regarding the prognostic
implication of various TBI cutoffs and the correlation to
angiographic ﬁndings. The purpose of this review is to
provide an overview of the evidence supporting the various
limits used for the TBI-based diagnosis of PAD.
GUIDELINE RECOMMENDATIONS
Ferket et al31 identiﬁed eight major guidelines in a
systematic review of PAD screening.1,23,32-38 The guide-
lines were evaluated with an Appraisal of Guidelines,
Research and Evaluation in Europe (AGREE) rigor score
varying from 33% to 81%. We reviewed the same guidelines
for statements regarding the use of TBI in the diagnosis of
PAD. These guidelines recommended an ABI <0.90 or
ABI #0.90 as the diagnostic limit, and only two of these
guidelines included statements for the use of the TBI.
The TransAtlantic Inter-Society Consensus for the
Management of Peripheral Arterial Disease (TASC II)
deﬁned a TBI <0.70 as an abnormal ﬁnding, but the
guidelines did not include references to support this.1
They emphasized that the importance of toe pressures
cannot be underestimated in diabetic patients with ulcers
due to the possibility of falsely elevated ankle pressures.
The American College of Cardiology Foundation
(ACCF) and American Heart Association (AHA) stated in
the ACCF/AHA 2011 guidelines2 that the TBI should be
used toestablish the lower extremity PADdiagnosis in patients
in whom the condition is suspected, and when the ABI test is
not reliable due to noncompressible vessels (longstanding dia-
betes or advanced age). The evidence supporting this was
graded as level B evidence. They did not specify diagnostic
cutoff levels in these guidelines. The ACCF/AHA 2005
guidelines23 deﬁned a TBI <0.7 as diagnostic for PAD;
however, none of the studies cited to support this cutoff value
advocated the use of a TBI <0.7 as a diagnostic limit.28,39-43
NORMAL RANGE
A limited number of studies have examined the normal
range of TBI in populations without vascular disease andshowed normal lower limits of TBI ranging from 0.49
to 0.74 (Table I).28,44-49 According to the Quality Assess-
ment of Diagnostic Accuracy Studies (QUADAS) 2 recom-
mendations for quality grading in diagnostic accuracy
studies, it is imperative to minimize the risk of bias by appro-
priate patient selection, using correct reference standard,
and adequately displaying data.50
Regarding patient selection, all studies except for one
(Williams et al, 2006) were established without using
imaging techniques to rule out arterial stenosis.44 The
high prevalence of PAD and the fact that >50% of PAD
patients are asymptomatic are important factors to consider
when assessing a reliable normal patient population.2,51 This
issue may be primarily relevant for normal values in elderly
populations. Arveschough et al, however, added blood
sample screening to exclude patients with arteriosclerotic
risk factors.45 In general, the recruitment process for healthy
volunteers for the normal populations for all studies was
insufﬁciently described and included coworkers, etc.
Regarding the appropriate use of reference standards,
all studies reported the use of pretest limb heating, except
the studies by Williams et al, Muro et al, and Brooks
et al.28,44,49 The lack of pretest heating could partly explain
the relatively low average TBI found in these studies. The
failure to include standardized pretest limb heating can
compromise reproducibility and lead to the measurement
of falsely low toe pressures.52,53
A number of different techniques are currently used for
the assessment of toe pressures in vascular laboratories,
including laser Doppler ﬂowmetry, photo plethysmog-
raphy, oscillometric plethysmography, and mercury-in-
silastic strain gauge plethysmography. These methods are
not fully interchangeable due to the differences in measure-
ment technologies and end points (DC or AC signals). For
example, photoplethysmography has been shown to
produce lower pressure readings than strain-gauge plethys-
mography and laser Doppler ﬂowmetry.54
Age and sex could be important factors, and different
reference values have been proposed for different age
groups.45 In the Fig, the mean age is plotted against TBI
ﬁndings from available sources. The data do not reveal an
evident discrepancy in the TBI across different age groups,
although the studies cannot be directly compared due to
the major differences in pretest preparation and technolo-
gies applied.
Overall, the primary limitations of the existing studies
include the lack of imaging techniques to exclude PAD,
small study sample sizes, inclusion of cohorts with inappro-
priate age distributions, and the use of different and likely
not directly comparable techniques. Finally, the general
acceptance of the limits stated as the mean 6 two standard
deviations is based on the assumption of a normal distribu-
tion of the TBI, which remains to be documented.
CORRELATION OF TBI TO ANGIOGRAPHIC
FINDINGS
Various methods, including duplex ultrasound imaging,
have been validated against contrast angiography for the
Fig. Data from the studies of toe-brachial index (TBI) in the
normal population that are listed in Table I. Values are the mean6
two standard deviations. The size of the dot representing the mean
illustrates the sample size. The clear dots represent studies with
preheating of the limb before blood pressure measurements. The
vertical line shows the weighted mean of the lower limit based on
studies using pretest limb heating.
Table I. Toe-brachial index (TBI) reference values in published articles ranked according to the mean age in a normal
population
Study (ﬁrst author) Year No. Mean age,a years Mean TBI Normal limitsb Method Pretest limb heating
Arveschough45 2008 31 76 (61-87) 0.92 0.62-1.22 SGP Yes
Williams44 2006 26 63 6 13 0.84 0.57-1.11 PP No
Muro49 2009 21 61 6 11 0.75 0.52-0.98 OP No
Brooks28 2001 53 53 6 15 0.71 0.49-0.93 PP or DT No
Carter57 1971 12 52 6 6 0.91 0.63-1.19 SGP Yes
Arveschough45 2008 14 51 (45-58) 0.95 0.73-1.17 SGP Yes
Sahli47 2004 134 50 6 12 0.93 0.74-1.12 PP Yes
Carter57 1971 16 21 6 4 0.86 0.62-1.10 SGP Yes
Average 0.86 0.62-1.10 All Yes/no
WAc 287 0.87 0.64-1.09 All Yes/no
WA pretest heating onlyc 207 0.92 0.71-1.14 All Yes
DT, Doppler-derived TBI; OP, oscillometric plethysmography; PP, photoplethysmography; SGP, strain-gauge plethysmography, WA, weighted average.
aMean age reported with the 6standard deviation or range.
bNormal limits were calculated as the mean 6 two standard deviations.
cThe weighted average takes into consideration the size of the study populations.
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#0.90 is considered robust in PAD diagnostics, a recent
systematic review showed a sensitivity ranging from 15% to
79% and a speciﬁcity from 83% to 100% for detecting
>50% vessel stenosis in the lower limb.6 The sensitivity was
particularly low in elderly patients and in patients with dia-
betes. A number of studies have included the TBI as well as
angiographic ﬁndings, but the primary end points in most
of these studies were not to assess the diagnostic accuracy
of the TBI, which can lead to heterogeneous data.29,48,56-58
The extracted studies are reported in Table II. Most of the
studies used highly selected populations, which does not
allow generalization due to the different prevalence of PAD
in the varying groups.1
According to the QUADAS-2 grading on the quality
of diagnostic accuracy studies, there is a risk of introducinga systematic bias when enrolling inappropriate study popu-
lations.50 As it was the case with the studies of normal
populations, the reference standard for the TBI is per-
formed by different methods and with inconsistent use of
pretest limb heating. A falsely low TBI would increase
the reported sensitivity.
In addition to appropriate patient selection and the use
of a correct reference standard, the QUADAS-2 recom-
mendations emphasize the importance of adequately dis-
playing the data. In several instances, the publications
only partially presented key data. Another problem is that
the extracted studies focused on PAD diagnosis on
a limb basis only and not on a patient basis.
In the 1971 study by Carter et al,57 a key study in
the determination of TBI reference values, the results from a
normal population (Table I) were transferred to 135 patients
with known PAD. They concluded that a TBI <0.64 was
abnormal.57 By using this cutoff, 121 of the 135 limbs with
angiographically veriﬁed stenosis had a TBI below the lower
limit of normal. This study remains one of themost frequently
quoted studies regarding TBI limits.
Only one study was identiﬁed that included a subgroup
of patients not primarily suspected of having PAD. In this
2005 study, Williams et al48 enrolled 88 patients with dia-
betes and a control population of 41 without diabetes.
They performed color duplex imaging to diagnose stenosis
of lower limb vessels and concluded that a TBI <0.75 was
an optimal cutoff with a high sensitivity and speciﬁcity for
detecting PAD for both patient groups (Table II). In
comparison, the Doppler-based ABI showed a sensitivity
of 83% for controls, 100% for diabetic patients without
peripheral neuropathy, and 53% for diabetic patients with
peripheral neuropathy when using an ABI <0.9 or ABI
>1.15 as the limit. The correspondent numbers for the
speciﬁcity were 100% for controls, 88% for diabetic patients
without peripheral neuropathy, and 95% for diabetic
patients with peripheral neuropathy.
Weinberg et al56 performed contrast angiography in
116 limbs of 92 patients with an ABI >1.40; of whom,
Table II. Sensitivity and speciﬁcity of the toe-brachial index (TBI) for detecting peripheral arterial disease (PAD) with
imaging technique as reference testsa
Study
(ﬁrst author) Year Population
Limbs,
No.
Low TBI,b
No. (%)
Stenosis,
No. (%)
Sensitivity,
%
Speciﬁcity,
%
PPV,
%
NPV,
%
TBI
limits Method
Pretest
limb
heating
Williams48 2005 Nondiabetic
controls
41 18 (44) 13 (32) 100 81 72 100 <0.75 PP No
Williams48 2005 Diabetes 88 43 (49) 22 (25) 91 65 47 96 <0.75 PP No
Weinberg56 2012 ABI >1.4 100 92 (92) 100 (100) 92 . . . <0.7 PP No
Carter57 1971 Known PAD 135 121 (90) 135 (100) 90 . . . <0.64 SGP Yes
Suominen29 2008 ABI >1.3 69 68 (99) 69 (100) 99 . . . <0.6 PP No
Suominen29 2008 ABI 0.9 to
<1.3
47 47 (100) 44 (94) . . 94 . <0.6 PP No
Park58 2012 Diabetic
gangrene
30 13 (43) 13 (43) 100 100 100 100 <0.6 PP No
ABI, Ankle-brachial index; NPV, negative predictive value; PP, photoplethysmography; PPV, positive predictive value; SGP, strain-gauge plethysmography.
aSensitivity, speciﬁcity, and predictive values are based on values or calculations based on data presented in the listed studies with each included limb analyzed
separately.
bNumber of included limbs with a low TBI and the percentage of the total. All ﬁndings were conﬁrmed by contrast angiography, except Williams et al48 who
used color duplex imaging.
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TBI <0.7 was found in 92% of patients with PAD
conﬁrmed by angiography. Suominen et al29 studied
1762 patients suspected of PAD that were referred to
a vascular center and performed digital subtraction angiog-
raphy in two subsets of these patients. The ﬁrst part,
including 69 patients with an ABI >1.3, all showed vessel
stenosis involving >50% of the lumen, of which only one
patient had TBI >0.6. In the second subset, which
included 47 patients with a normal ABI but a TBI <0.6,
the researchers conﬁrmed the presence of signiﬁcant
stenosis in 44 patients (94%) by angiography. Park et al58
performed infrapopliteal angiography in both limbs in
patients with diabetic gangrene and suspected arterial
insufﬁciency. They included patients with reduced TBI
(<0.6) or ABI (<0.9) in at least one limb. Among this
group, 13 of the 30 limbs presented with a pathologic
TBI. The TBI showed a sensitivity of 100% and a speciﬁcity
of 100% for detecting a vessel stenosis per limb requiring
subsequent intervention. In contrast, the ABI showed
a sensitivity of 38% and a speciﬁcity of 88% in this highly
selective cohort. It was not reported whether the observers
were blinded to the results of the reference or the index
test, or both, which is a key issue in studies of diagnostic
accuracy and may introduce a source of bias.59
ASSOCIATION OF TBI TO MORBIDITY AND
MORTALITY
Cardiovascular disease and mortality. So far, only
a few studies have described the prognostic effect on cardio-
vascular disease and mortality of having a pathologic TBI and
a normal ABI. In the San Diego Population Study, Criqui
et al60-64 performed PAD screening on a geographically
deﬁned population of 624 individuals as a part of a study on
dyslipidemia. By using an ABI #0.8 and a TBI #0.7 as
diagnostic limits and diagnosis based on pulse reappearance
time, 14% of the population presented with isolated low toepressures.61 A 10-year follow-up of this small study sample
of 90 revealed a 2.6 times increased risk of cardiovascular
death in patients with an isolated reduced TBI compared
with those with normal pressure indices.64 Nonetheless, they
showed that patients with a low TBI but a normal ABI were
epidemiologically distinct from patients with a low ABI
because they had a lower frequency of smokers, were less
likely to be obese, had a lower fasting glucose levels, and
were younger.60
In comparison, Suominen et al7 conducted an analysis of
patients referred to a vascular clinic with suspicion of PAD. A
total of 27% in the cohort had a TBI<0.6 and an ABI>0.9;
of these, >40% were reported to have chronic kidney failure
or diabetes. PAD diagnosed by TBI was independently asso-
ciated with all-cause and cardiovascular mortality in patients
with an ABI >1.3. In a study of 309 patients with
a TBI <0.10 and a low-pulse amplitude, an increased risk
of the overall and cardiovascular 5-year death rate was re-
ported.42 Regarding cardiovascular disease, Papanas et al65
showed an association with the TBI and coronary artery
stenosis conﬁrmed on coronary angiography.
Normal ABI but low TBI. The prevalence of having
a low TBI but a normal ABI ranges from 9% to 27% in
different large-scale studies (n > 100; Table III). The
ﬁndings are, however, not comparable due to the hetero-
geneous study populations, different diagnostic limits used,
and substantial methodologic differences. Three studies
included patients suspected of PAD and showed a normal
ABI but a low TBI in 16% to 27%. In these studies, a high
pretest likelihood of having the disease was expected, as
was the case in studies of patients with diabetes or chronic
kidney disease.
Disease progression. Bird et al15 performed repeated
distal pressure assessments in 755 limbs in 423 patients
referred to a vascular laboratory at the San Diego Veterans
Administration Medical Center, with a mean follow-up of
4.6 years. They identiﬁed 106 patients (14%) with
Table III. Prevalence of patients with a low toe-brachial index (TBI) and a normal ankle-brachial index (ABI)
Study
(ﬁrst author) Year No.
Low TBI,
normal ABI, %
Diagnostic limits
Population Method
Pretest limb
heatingABI TBI
Sahli47 2004 303 9a >0.9 <0.74 Diabetic patients PP Yes
Bird15 1999 423 14a >0.9 #0.7 Patients suspected of PAD PP No
Høyer16 2012 204 17 >0.9 <0.7 Patients suspected of PAD SGP Yes
Crique14,60 1985 613 16 >0.8 #0.7 Screening population SGP No
Morimoto71 2009 115 11 >0.9 <0.6 Patients in hemodialysis OP No
Suominen7 2010 2159 27 >0.9 <0.6 Patients suspected of PAD PP No
OP, Oscillometric plethysmography; PP, photoplethysmography; SGP, strain gauge plethysmography.
aEach limb diagnosed independently.
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>0.9, and normal posterior tibial ﬂow velocity. At follow-
up, 41 (39%) had a normal TBI and ABI, 30 (28%) had
an unchanged isolated low TBI, and 35 (33%) had a low
ABI. Aboyans et al66 did a similar follow-up study (mean,
4.6 years) of 403 patients from the same vascular labora-
tory using the same diagnostic limits. They deﬁned
a decline of 0.27 for the TBI and 0.30 for the ABI
(highest decile) as an indicator of major progression. They
showed that cigarette smoking, lipids, and inﬂammation
contributed to progression in patients with a low ABI,
whereas diabetes was a signiﬁcant predictor of patients with
an isolated low TBI.
Diabetes. The presence of diabetes is a well-described
risk factor for the development of arteriosclerosis, and the
ABI is considered less reliable than the TBI in this pop-
ulation due to the high prevalence of media calciﬁcation.1,12
A large study with >500 patients showed a linear relation-
ship between the TBI and the ABI in nondiabetic patients
but had an inverted J-shape relationship in diabetic
patients.67 This indicated that a high ABI in diabetic patients
masked the presence of lower limb ischemia. A similar
conclusion was asserted in a study using an isotope-washout
technique.68 These studies consistently showed that the ABI
underestimated the severity of PAD in patients with dia-
betes. Furthermore, studies have shown that the TBI ismore
closely associated with estimated glomerular ﬁltration rate,
the degree of albuminuria,69 and the presence of peripheral
neuropathy48 in patients with diabetes.
Sahli et al47 screened a diabetic population for PAD
and showed that 9% of the included limbs had an isolated
low TBI. On the basis of their own normal population
data (Table I), they applied a TBI <0.74 and an
ABI <0.90 as diagnostic limits. They showed that the
TBI is independently associated with the fasting blood
glucose, smoking status, age, and the duration of diabetes.
A 10-year follow-up was planned, but no data have yet
been presented in the public domain.
Chronic kidney disease. Patients with chronic kidney
disease have a high risk of developing generalized athero-
sclerosis and a high prevalence of media calciﬁcation.70
Morimoto et al71 identiﬁed that 11% of patients with
chronic kidney failure on hemodialysis (n ¼ 220) had an
ABI $0.9 and a TBI <0.6. They did not analyze outcomesregarding mortality; however, they showed that a ﬁnding
of an isolated low TBI was associated with risk factors such
as diabetes and excess body weight. Moreover, studies have
shown that TBI is a predictor of outcome after kidney
transplantation.72
Microvascular disease. Some authors have considered
the TBI as a marker of the early phase of arteriosclerotic
development and low ABI as a manifestation of an advanced
arteriosclerotic condition.73 In support of this argument,
studies have shown the TBI has a stronger association than
the ABI with diseases involving the microvasculature such as
erectile dysfunction74 and systemic sclerosis.49 Another
study showed that tissue plasminogen activator activity,
which is an indicator of vascular injury, was associated with
having a TBI <0.74.73
DISCUSSION
The measurement of absolute toe pressures is well vali-
dated in the diagnosis of critical limb ischemia and is a prog-
nostic marker for wound healing.42,43,75 However, this
review shows that the use of the TBI for the diagnosis of
PAD remains ambiguous, as summarized in Table IV. On
the basis of the available clinical information on normal pop-
ulations, correlation to angiographic ﬁndings, mortality, and
comorbidities, it is evident that a substantial divergence
exists regarding speciﬁc TBI limits. Although several guide-
lines and reviews of PAD diagnostics24-27 recommend a TBI
of <0.70 as the cutoff, this recommendation is not strictly
evidence based. In addition, other limits are frequently
used in observational studies and clinical settings, among
them TBI <0.75,44 <0.74,47 <0.65,72 <0.64,18,76,77
<0.60,7,10,29,65,71 or #0.54.28 The use of different and
not fully interchangeable measuring techniques and non-
standardized measurements, such as pretest heating, are
important issues that may compromise generalizability of
these studies.50 The extracted normal material is sparse
and includes limited use of imaging techniques to exclude
the PAD diagnosis. The studies on the correlation with
angiographic ﬁndings are mainly performed in highly
selected patient populations. Nonetheless, these studies
suggest a high sensitivity of 90% to 100% for the detection
of vessel stenosis, regardless of the diagnostic limit used.
The current literature is not sufﬁcient to conclude
a speciﬁc cutoff as diagnostic for PAD. We estimated
Table IV. Potential role of the toe-brachial index (TBI) and absolute toe pressuresa
Absolute toe pressures Diagnosis of critical limb ischemia (level B evidence)75
Prognostic marker for distal wound healing (level B evidence)42,43
TBI Diagnosis of PAD (remains to be clariﬁed)
Prognostic marker for cardiovascular morbidity and mortality (remains to be clariﬁed)
PAD, Peripheral arterial disease.
aGrading of evidence adopted as used by the American College of Cardiology Foundation/American Heart Association guidelines.2
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on the weighted average in studies with preheating of the
limbs. The exact limits await properly conducted diagnostic
accuracy studies performed in accordance with the current
methodologic requirements.78,79 In comparison, the diag-
nostic boundaries of the ABI are not deﬁned by a normal
population but by the association with angiographic ﬁnd-
ings and hard end points such as cardiovascular morbidity
and mortality.3,4
As mentioned earlier, a systematic review has shown
a large discrepancy in the reported diagnostic value for an
ABI to detect arterial stenosis in the lower limb, which
questions the use of an ABI #0.90 as the cutoff. An ABI
of 0.91 to 1.00 has been suggested to constitute a border-
line abnormal ﬁnding due to the increased mortality
compared with patients with an ABI of 1.00 to 1.30.3 It
could be hypothesized that borderline classiﬁcation is also
required for the TBI, although this remains speculative.
Studies have shown that approximately one-third of the
patients with a TBI <0.7 and a normal ABI progress to
an abnormal ABI after a 4.6-year follow-up,15 which would
imply that these patients should receive additional vascular
control.
Some have proposed that a low TBI in the setting of
a normal ABI reﬂects small-vessel disease, whereas patients
with a low ABI have large-vessel disease.60,66 However, the
pathophysiology ismost likelymore complex than the dichot-
omous answer of PAD/not PAD. For instance, a proportion
of patients in the subgroup with vessel stiffness would
produce a falsely normal ABI and mask the presence of true
large-vessel disease.8,9,29 Another subgroup of patients could
have vessel stenosis below the ankle level and have minor
vessel disease.60Moreover, because the toe vessels are known
to be susceptible to vasoconstriction,80 patients without PAD
could falsely be classiﬁed as having a low TBI. This effect can
be minimized by measuring the TBI under standardized
conditions, such as using rooms with stable temperatures
and implementing pretest limb heating.52,53 Under standard-
ized conditions, the day-to-day variation of toe pressures
seems comparable to that of ankle pressures.81
Methods used for measurement of toe blood pressures
use different detection systems. Systematically biased values
of the TBI among systems should be taken into account
when assessing the diagnostic and prognostic effect of
such measurements. Such considerations have been high-
lighted for ABI measurements as well.4 The inﬂuence of
experimental conditions, such as skin temperature, may
differ among systems, and it would be advisable for each
vascular laboratory to establish quality criteria forexperimental conditions and reproducibility to optimize
the diagnostic accuracy and precision.
CONCLUSIONS
Regardless of the ambiguous deﬁnition of diagnostic
limits, there is an interesting correlation between the
TBI and comorbidities, such as kidney disease and diabetes,
which suggests that the TBI, in some aspects, is more valid
than the ABI. This shows that the TBI has a place in vascular
diagnostics, although the exact role remains to be clariﬁed. In
the current screening algorithms, the TBI is primarily applied
in selected patient cohorts where vascular stiffness is sus-
pected.1,2 However, studies have indicated that a large subset
of patients have a low TBI and a normal ABI, even in patients
not suspected of vascular stiffness.7,16 The TBI could be used
alone or combined with the ABI to select patients eligible
for a full vascular examination. Implementing the TBI as
a primary gatekeeper in screening algorithms could thus allow
for detection of patientswith PADwho remain undetected by
the current algorithms.However, large-scale trials are needed
to establish the risk of morbidity and mortality for the various
diagnostic limits of the TBI. The current studies of normal
populations and the correlation with angiography are few
in numbers, and additional trials according to the recommen-
dations of Standards for Reporting of Diagnostic Accuracy
Studies78 and Cochrane Diagnostic test accuracy79 are
needed to further validate the limits. This is particularly
relevant with the introduction of new methods for PAD
screening, that are based on the TBI, which may supplement
or even substitute for the ABI.18
AUTHOR CONTRIBUTIONS
Conception and design: CH, JS, LP
Analysis and interpretation: CH, JS, LP
Data collection: CH, JS, LP
Writing the article: CH, JS, LP
Critical revision of the article: CH, JS, LP
Final approval of the article: CH, JS, LP
Statistical analysis: CH, JS, LP
Obtained funding: Not applicable
Overall responsibility: CH
REFERENCES
1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA,
Fowkes FG, et al. Inter-Society Consensus for the Management of
Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg
2007;33(Suppl 1):S1-75.
2. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK,
et al. 2011 ACCF/AHA focused update of the guideline for the
JOURNAL OF VASCULAR SURGERY
Volume 58, Number 1 Høyer et al 237management of patients with peripheral artery disease (updating the
2005 Guideline). A report of the American College of Cardiology
Foundation/American Heart Association Task Force on Practice
Guidelines. J Am Coll Cardiol 2011;58:2020-45.
3. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE,
et al. Ankle brachial index combined with Framingham Risk Score to
predict cardiovascular events and mortality: a meta-analysis. JAMA
2008;300:197-208.
4. Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA,
Diehm C, et al. Measurement and interpretation of the ankle-brachial
index: a scientiﬁc statement from the American Heart Association.
Circulation 2012;126:2890-909.
5. Aboyans V, McClelland RL, Allison MA, McDermott MM,
Blumenthal RS, Macura K, et al. Lower extremity peripheral artery
disease in the absence of traditional risk factors. The Multi-Ethnic
Study of Atherosclerosis. Atherosclerosis 2011;214:169-73.
6. Dachun X, Jue L, Liling Z, Yawei X, Dayi H, Pagoto SL, et al. Sensitivity
and speciﬁcity of the ankle-brachial index to diagnose peripheral artery
disease: a structured review. Vasc Med 2010;15:361-9.
7. Suominen V, Uurto I, Saarinen J, Venermo M, Salenius J. PAD as a risk
factor for mortality among patients with elevated ABIda clinical study.
Eur J Vasc Endovasc Surg 2010;39:316-22.
8. Potier L, Halbron M, Bouilloud F, Dadon M, Le DJ, Ha VG, et al.
Ankle-to-brachial ratio index underestimates the prevalence of
peripheral occlusive disease in diabetic patients at high risk for arterial
disease. Diabetes Care 2009;32:e44.
9. Emanuele MA, Buchanan BJ, Abraira C. Elevated leg systolic pressures
and arterial calciﬁcation in diabetic occlusive vascular disease. Diabetes
Care 1981;4:289-92.
10. Leskinen Y, Salenius JP, Lehtimaki T, Huhtala H, Saha H. The prev-
alence of peripheral arterial disease and medial arterial calciﬁcation in
patients with chronic renal failure: requirements for diagnostics. Am J
Kidney Dis 2002;40:472-9.
11. Young MJ, Adams JE, Anderson GF, Boulton AJ, Cavanagh PR.
Medial arterial calciﬁcation in the feet of diabetic patients and matched
non-diabetic control subjects. Diabetologia 1993;36:615-21.
12. Ix JH, Miller RG, Criqui MH, Orchard TJ. Test characteristics of the
ankle-brachial index and ankle-brachial difference for medial arterial
calciﬁcation on X-ray in type 1 diabetes. J Vasc Surg 2012;56:721-7.
13. Mukherjee D, Eagle K. The importance of early diagnosis and treat-
ment in peripheral arterial disease: insights from the PARTNERS and
REACH registries. Curr Vasc Pharmacol 2010;8:293-300.
14. Criqui MH. Peripheral arterial disease-epidemiological aspects. Vasc
Med 2001;6(3 Suppl):3-7.
15. Bird CE, Criqui MH, Fronek A, Denenberg JO, Klauber MR,
Langer RD. Quantitative and qualitative progression of peripheral
arterial disease by non-invasive testing. Vasc Med 1999;4:15-21.
16. Høyer C, Sandermann J, Petersen LJ. Randomised diagnostic accuracy
study of a fully automated portable device for diagnosing peripheral
arterial disease by measuring the toe-brachial index. Eur J Vasc
Endovasc Surg 2013;45:57-64.
17. Kroger K, Stewen C, Santosa F, Rudofsky G. Toe pressure measure-
ments compared to ankle artery pressure measurements. Angiology
2003;54:39-44.
18. Bonham P. Measuring toe pressures using a portable photoplethysmo-
graph to detect arterial disease in high-risk patients: an overview of the
literature. Ostomy Wound Manage 2011;57:36-44.
19. Perez-Martin A, Meyer G, Demattei C, Boge G, Laroche JP, Quere I,
et al. Validation of a fully automatic photoplethysmographic device for
toe blood pressure measurement. Eur J Vasc Endovasc Surg 2010;40:
515-20.
20. Bonham PA, Kelechi T, Mueller M, Robison J. Are toe pressures
measured by a portable photophlethysmograph equivalent to standard
laboratory tests? J Wound Ostomy Continence Nurs 2010;37:475-86.
21. Harrison ML, Lin HF, Blakely DW, Tanaka H. Preliminary assessment
of an automatic screening device for peripheral arterial disease using
ankle-brachial and toe-brachial indices. Blood Press Monit 2011;16:
138-41.
22. Widmer LW, Vikatmaa P, Aho P, Lepantalo M, Venermo M. Reli-
ability and repeatability of toe pressures measured with laser Dopplerand portable and stationary photoplethysmography devices. Ann Vasc
Surg 2012;26:404-10.
23. HirschAT,Haskal ZJ,Hertzer NR, BakalCW,CreagerMA,Halperin JL,
et al. ACC/AHA 2005 Practice Guidelines for the management of
patients withperipheral arterial disease (lower extremity, renal,mesenteric,
and abdominal aortic): a collaborative report from the American Associ-
ation for Vascular Surgery/Society for Vascular Surgery, Society for
Cardiovascular Angiography and Interventions, Society for Vascular
Medicine and Biology, Society of Interventional Radiology, and the
ACC/AHA Task Force on Practice Guidelines (Writing Committee to
Develop Guidelines for the Management of Patients With Peripheral
Arterial Disease): endorsed by theAmericanAssociation of Cardiovascular
and Pulmonary Rehabilitation; National Heart, Lung, and Blood Insti-
tute; Society forVascularNursing;TransAtlantic Inter-SocietyConsensus;
and Vascular Disease Foundation. Circulation 2006;113:e463-654.
24. Lau JF,WeinbergMD,Olin JW. Peripheral artery disease. Part 1: clinical
evaluation and noninvasive diagnosis. Nat Rev Cardiol 2011;8:405-18.
25. Azam SM, Carman TL. Diagnostic approach to peripheral arterial
disease. Cardiol Clin 2011;29:319-29.
26. Chan D, Anderson ME, Dolmatch BL. Imaging evaluation of lower
extremity infrainguinal disease: role of the noninvasive vascular labo-
ratory, computed tomography angiography, and magnetic resonance
angiography. Tech Vasc Interv Radiol 2010;13:11-22.
27. Begelman SM, Jaff MR. Noninvasive diagnostic strategies for periph-
eral arterial disease. Cleve Clin J Med 2006;73(Suppl 4):S22-9.
28. Brooks B, Dean R, Patel S, Wu B, Molyneaux L, Yue DK. TBI or not
TBI: that is the question. Is it better to measure toe pressure than ankle
pressure in diabetic patients? Diabet Med 2001;18:528-32.
29. Suominen V, Rantanen T, Venermo M, Saarinen J, Salenius J. Preva-
lence and risk factors of PAD among patients with elevated ABI. Eur J
Vasc Endovasc Surg 2008;35:709-14.
30. Sahli D, Svensson M, Lidgren J, Ojbrandt K, Eriksson JW. Evaluation
of simple non-invasive techniques for assessment of lower extremity
arterial disease. Clin Physiol Funct Imaging 2005;25:129-34.
31. Ferket BS, Spronk S, Colkesen EB, Hunink MG. Systematic review of
guidelines on peripheral artery disease screening. Am J Med 2012;125:
198-208.
32. Using nontraditional risk factors in coronary heart disease risk assess-
ment: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med 2009;151:474-82.
33. Screening for peripheral arterial disease: recommendation statement.
Am Fam Physician 2006;73:497-500.
34. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA,
et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk
in asymptomatic adults: a report of the American College of Cardiology
Foundation/American Heart Association Task Force on Practice
Guidelines. Circulation 2010;122:e584-636.
35. Third Report of the National Cholesterol Education Program (NCEP)
Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (Adult Treatment Panel III) ﬁnal report. Circu-
lation 2002;106:3143-421.
36. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT,
Hunninghake DB, et al. Implications of recent clinical trials for the
National Cholesterol Education Program Adult Treatment Panel III
guidelines. Circulation 2004;110:227-39.
37. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N,
Carpentier A, et al. 2009 Canadian Cardiovascular Society/Canadian
guidelines for the diagnosis and treatment of dyslipidemia and
prevention of cardiovascular disease in the adultd2009 recommenda-
tions. Can J Cardiol 2009;25:567-79.
38. Abramson BL, Huckell V, Anand S, Forbes T, Gupta A, Harris K, et al.
Canadian Cardiovascular Society Consensus Conference: peripheral
arterial diseasedexecutive summary. Can J Cardiol 2005;21:997-1006.
39. Carter SA. Indirect systolic pressures and pulse waves in arterial occlusive
diseases of the lower extremities. Circulation 1968;37:624-37.
40. Carter SA. Clinical measurement of systolic pressures in limbs with
arterial occlusive disease. JAMA 1969;207:1869-74.
41. Carter SA, Tate RB. Value of toe pulse waves in addition to systolic
pressures in the assessment of the severity of peripheral arterial disease
and critical limb ischemia. J Vasc Surg 1996;24:258-65.
JOURNAL OF VASCULAR SURGERY
238 Høyer et al July 201342. Carter SA, Tate RB. The value of toe pulse waves in determination
of risks for limb amputation and death in patients with peripheral
arterial disease and skin ulcers or gangrene. J Vasc Surg 2001;33:
708-14.
43. Ramsey DE, Manke DA, Sumner DS. Toe blood pressure. A valuable
adjunct to ankle pressure measurement for assessing peripheral arterial
disease. J Cardiovasc Surg (Torino) 1983;24:43-8.
44. Williams DT, Price P, Harding KG. The inﬂuence of diabetes and
lower limb arterial disease on cutaneous foot perfusion. J Vasc Surg
2006;44:770-5.
45. Arveschoug AK, Vammen B, Yoshinaka E, Sorensen D, Jodal L,
Brochner-Mortensen J. Reference data for distal blood pressure in
healthy elderly and middle-aged individuals measured with the strain
gauge technique. Part I: resting distal blood pressure. Scand J Clin Lab
Invest 2008;68:249-53.
46. Carter SA. Ankle and toe systolic pressures comparison of value and
limitations in arterial occlusive disease. Int Angiol 1992;11:289-97.
47. Sahli D, Eliasson B, Svensson M, Blohme G, Eliasson M, Samuelsson P,
et al. Assessment of toe blood pressure is an effective screening method
to identify diabetes patients with lower extremity arterial disease.
Angiology 2004;55:641-51.
48. Williams DT, Harding KG, Price P. An evaluation of the efﬁcacy of
methods used in screening for lower-limb arterial disease in diabetes.
Diabetes Care 2005;28:2206-10.
49. Muro Y, Sugiura K, Morita Y, Tomita Y. An evaluation of the efﬁcacy
of the toe brachial index measuring vascular involvement in systemic
sclerosis and other connective tissue diseases. Clin Exp Rheumatol
2009;27(3 Suppl 54):26-31.
50. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ,
Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment
of diagnostic accuracy studies. Ann Intern Med 2011;155:529-36.
51. Criqui MH. Systemic atherosclerosis risk and the mandate for inter-
vention in atherosclerotic peripheral arterial disease. Am J Cardiol
2001;88:43J-7J.
52. Sawka AM, Carter SA. Effect of temperature on digital systolic pres-
sures in lower limb in arterial disease. Circulation 1992;85:1097-101.
53. McCollum PT, Stanley ST, Kent P, Grouden MC, Moore DJ,
Shanik GD. Assessment of arterial disease using digital systolic pressure
measurement. Ann Vasc Surg 1988;2:349-51.
54. Ubbink DT. Toe blood pressure measurements in patients sus-
pected of leg ischaemia: a new laser Doppler device compared
with photoplethysmography. Eur J Vasc Endovasc Surg 2004;27:
629-34.
55. Collins R, Burch J, Cranny G, Aguiar-Ibanez R, Craig D, Wright K,
et al. Duplex ultrasonography, magnetic resonance angiography, and
computed tomography angiography for diagnosis and assessment of
symptomatic, lower limb peripheral arterial disease: systematic review.
BMJ 2007;334:1257.
56. Weinberg I, Giri J, Calfon MA, Hawkins BM, Weinberg MD,
Margey R, et al. Anatomic correlates of supra-normal ankle brachial
indices. Catheter Cardiovasc Interv 2012. http://dx.doi.org/10.
1002/ccd.24604; [Epub ahead of print].
57. Carter SA, Lezack JD. Digital systolic pressures in the lower limb in
arterial disease. Circulation 1971;43:905-14.
58. Park CS, Choi CY, Ha YI, Yang HE. Utility of toe-brachial index for
diagnosis of peripheral artery disease. Arch Plast Surg 2012;39:227-31.
59. Lucas NP, Macaskill P, Irwig L, Bogduk N. The development of
a quality appraisal tool for studies of diagnostic reliability (QAREL).
J Clin Epidemiol 2010;63:854-61.
60. Criqui MH, Browner D, Fronek A, Klauber MR, Coughlin SS, Barrett-
Connor E, et al. Peripheral arterial disease in large vessels is epidemi-
ologically distinct from small vessel disease. An analysis of risk factors.
Am J Epidemiol 1989;129:1110-9.
61. CriquiMH,Coughlin SS, Fronek A.Noninvasively diagnosed peripheral
arterial disease as a predictor of mortality: results from a prospective
study. Circulation 1985;72:768-73.
62. Criqui MH, Fronek A, Klauber MR, Barrett-Connor E, Gabriel S. The
sensitivity, speciﬁcity, and predictive value of traditional clinical evalu-
ation of peripheral arterial disease: results from noninvasive testing in
a deﬁned population. Circulation 1985;71:516-22.63. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S,
Goodman D. The prevalence of peripheral arterial disease in a deﬁned
population. Circulation 1985;71:510-5.
64. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR. Large
vessel and isolated small vessel disease. In: Fowkes FG, editor. Epide-
miology of peripheral arterial disease. London: Springer-Verlag; 1991.
p. 85-96.
65. Papanas N, Tziakas D, Maltezos E, Kekes A, Hatzinikolaou E,
Parcharidis G, et al. Peripheral arterial occlusive disease as a predictor of
the extent of coronary atherosclerosis in patients with coronary artery
disease with and without diabetes mellitus. J IntMedRes 2004;32:422-8.
66. Aboyans V, Criqui MH, Denenberg JO, Knoke JD, Ridker PM,
Fronek A. Risk factors for progression of peripheral arterial disease in
large and small vessels. Circulation 2006;113:2623-9.
67. Aboyans V, Ho E, Denenberg JO, Ho LA, Natarajan L, Criqui MH.
The association between elevated ankle systolic pressures and peripheral
occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc
Surg 2008;48:1197-203.
68. Quigley FG, Faris IB, Duncan HJ. A comparison of Doppler ankle
pressures and skin perfusion pressure in subjects with and without
diabetes. Clin Physiol 1991;11:21-5.
69. Fukui M, Tanaka M, Hamaguchi M, Senmaru T, Sakabe K, Asano M,
et al. Toe-brachial index is associated more strongly with albuminuria
or glomerular ﬁltration rate than ankle-brachial index in patients with
type 2 diabetes. Hypertens Res 2012;35:745-9.
70. Garimella PS, Hart PD, O’Hare A, Deloach S, Herzog CA, Hirsch AT.
Peripheral artery disease and CKD: a focus on peripheral artery disease as
a critical component of CKD care. Am J Kidney Dis 2012;60:641-54.
71. Morimoto S, Nakajima F, Yurugi T, Morita T, Jo F, Nishikawa M, et al.
Risk factors of normal ankle-brachial index and low toe-brachial index
in hemodialysis patients. Ther Apher Dial 2009;13:103-7.
72. Mäkisalo H, Lepantalo M, Halme L, Lund T, Peltonen S, Salmela K,
et al. Peripheral arterial disease as a predictor of outcome after renal
transplantation. Transpl Int 1998;11(Suppl 1):S140-3.
73. Sahli D, Eriksson JW, Boman K, Svensson MK. Tissue plasminogen
activator (tPA) activity is a novel and early marker of asymptomatic
LEAD in type 2 diabetes. Thromb Res 2009;123:701-6.
74. Fukui M, Tanaka M, Okada H, Iwase H, Mineoka Y, Senmaru T, et al.
Five-item version of the international index of erectile function corre-
lated with albuminuria and subclinical atherosclerosis in men with type
2 diabetes. J Atheroscler Thromb 2011;18:991-7.
75. Becker F, Robert-Ebadi H, Ricco JB, Setacci C, Cao P, de DG, et al.
Chapter I: deﬁnitions, epidemiology, clinical presentation and prog-
nosis. Eur J Vasc Endovasc Surg 2011;42(Suppl 2):S4-12.
76. Reinhard H, Wiinberg N, Hansen PR, Kjaer A, Petersen CL,
Winther K, et al. NT-proBNP levels, atherosclerosis and vascular
function in asymptomatic type 2 diabetic patients with micro-
albuminuria: peripheral reactive hyperaemia index but not NT-proBNP
is an independent predictor of coronary atherosclerosis. Cardiovasc
Diabetol 2011;10:71.
77. Kallio M, Forsblom C, Groop PH, Groop L, LepantaloM. Development
of new peripheral arterial occlusive disease in patients with type 2 diabetes
during a mean follow-up of 11 years. Diabetes Care 2003;26:1241-5.
78. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP,
Irwig LM, et al. Towards complete and accurate reporting of studies of
diagnostic accuracy: the STARD initiative. Standards for Reporting of
Diagnostic Accuracy. Clin Chem 2003;49:1-6.
79. Reitsma JB, Rutjes AWS, Whiting P, Vlassov VV, Leeﬂang MMG,
Deeks JJ. Assessing methodological quality. In: Deeks JJ, Bossuyt PM,
Gatsonis C, editors. Cochrane handbook for systematic reviews of
diagnostic test accuracy. 1.0 ed. Oxford, UK: The Cochrane Collab-
oration; 2009.
80. Wright CI, Kroner CI, Draijer R. Non-invasive methods and stimuli for
evaluating the skin’s microcirculation. J Pharmacol Toxicol Methods
2006;54:1-25.
81. Arveschoug AK, Revsbech P, Brochner-Mortensen J. Sources of vari-
ation in the determination of distal blood pressure measured using the
strain gauge technique. Clin Physiol 1998;18:361-8.
Submitted Jan 9, 2013; accepted Mar 24, 2013.
